Opus Genetics Inc. – Filings and Transcripts

NASDAQ: IRD
Share price (7/17/26): $3.27
Market cap (7/17/26): $270 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus for primary offering

Shelf registration

Registration of securities for employees

Shelf registration – amended

Shelf registration

Ownership Filter

Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness, Inc.

Foundation Fighting Blindness Retinal Degeneration Fund

Caligan Partners LP

Perceptive Advisors LLC

Balyasny Asset Management L.P.

News Filter

Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients With Inherited Retinal Diseases

Investor Presentation

Announces Financial Results for First Quarter 2026 and Provides Corporate Update

New Financial Obligation or Off-Balance Sheet Arrangement

Shareholder Vote Results

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Letter to shareholders

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC